Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANTG-adip for Depressed Scar
NCT00992147Phase 3Completed
- Sponsor
- Anterogen Co., Ltd.
- Start
- May 2004
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 3 trial of allo-asc in atrophic scar, sponsored by Anterogen Co., Ltd.. Started May 2004; status: completed.
02
Drugs
allo-asc
03
Conditions
atrophic scar
Beyond the preview
Go deeper on NCT00992147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00992147.